NASDAQ:NVAX We got our pop higher on NVAX but we hit right into resistance. We still have bullish momentum trying to get through this level but if that weakens this could be another trap. This stock has the tendency to be extremely volatile so take your gains when you got them and don't stay in based off hopes and dreams.
Fundamental Quidel: a manufacturer of diagnostic products, frequently rises or sinks in response to developments in the coronavirus pandemic, as a big part of their revenue comes from its COVID-19 testing kits. As the Delta Variant is worrying countries around the globe, QDEL will be interesting to watch. Technical Analysis As you can see in the weekly ...
Based on SP500 rejecting a key level and on the Low time frame France 40 showing a significant rejection. We have a chance of going for the lows. Currently short with a stop at 6533. The political situation in France is also getting worse with mass protests against vaccine passport.
On 4/20/2021 HC Wainwright brokerage Reiterated Rating to Buy and a Price Target of $16.00 for NRBO But how come? What`s the catalyst? Why NeuroBo Pharmaceuticals was up 40% yesterday? Richard J. Kang, CEO: "Throughout the first quarter of 2021, we continued to make progress advancing the 60-patient Phase 2/3 clinical trial of our lead drug candidate, ANA001,...
Since Covid-19 is here to stay with us with its variants and the vaccines don`t offer lifetime protection, this means that there is room for other companies to develop a better vaccine to address the problem. And the gains in vaccines stock are quite similar to cryptocurrencies year over year. From all time low to all time high, BNTX made 19X, MRNA 24X and NVAX...
On 6/15/2021 Cantor Fitzgerald brokerage Boosted the Price Target from Reduce to Overweight $217.00 to $272.00 On 5/18/2021 JPMorgan Chase & Co. brokerage Reiterated Rating from Overweight to Neutral $285.00 to $161.00 On 5/12/2021 B. Riley brokerage Lowered the Price Target from $365.00 to $286.00 On 5/12/2021 HC Wainwright brokerage Lowered the...
Supposedly the beneficiary of the vaccine story as one of the appointees approved by the government. A duopoly with DPHARMA. However... their price & volume action is dimming fast.. The cup and handle pattern is invalidated. The recent decision to prioritize Pfizer vaccine over Sinovac really trigger a sell-down on PHARMA stock price with high volume. Expect...
Celsion is at a key support level & may bounce at this point. Potential move to 600 ema? Seeing multiple confluences. Volume is extremely low. Potential news? Keeping an eye on this one. Lot's in the works.
NVAX about to break from an descending triangle with good risk to reward ratio
Symbol Update NASDAQ:NVAX
THE BIG LONG! Vaccine for the Covid-Mutants! :-) ENTRY: 44.20 EUR TARGET: 90.00 EUR (104 % profit) STOP: 32.40 EUR - This is only an interim analysis result of the CUREVAC Covid vaccince!! - Initial analyzes have shown that the effectiveness depends on the age group examined and the virus strains, the company continues. - The vaccine candidate is in the final...
Symbol: NASDAQ:NVAX Top Indicator: Laguerre RSI Bottom Indicator: Tradingview MACD Here is a pattern based off of Fractals. We have a divergence in the MACD and two big trendlines coming into play. We could see a big move either way here, price has been hanging out after a solid move up and the dips are getting bought but we haven't broken out yet.
WITH BIG NEW FROM PRESIDENT BIDEN THIS WEEK SUPPLYING OVER 500 MILLION VACCINES AROUND THE WORLD. PFIZER LOOKS READY FOR ITS NEXT BULL RUN, WITH A PERFECT ENTRY BUY CANDLE ON THE WEEKLY TIMEFRAME. #BLESSEDPIPS
NASDAQ:NVAX Looking strong here but may get caught up a bit.
This is a purely technical and the current market euphoria call. Expect $VBIV making $MRNA, $VIR like stratospheric moves. Target trend lines. SL: $2.6
Seeing a Volatility Contraction Pattern (VCP) from the 3 hour time frame with a Parabolic SAR switching below the candles. I'm very bullish on OCGN since during the April 30th overall market bearishness, OCGN holds its place and is the only green candle in my watchlist. Another thing to look is from the weekly time frame which in my technical analysis using the...
MRNA has had a few wild weeks going up from $120 to $170. I believe this could be the end of the bullishness and it may do a correction. Why do I believe this could happen? MRNA hit historic resistance of $170, after hitting that mark it began dropping. This resistance seems like it can hold. RSI is bounced off the 70 mark on the daily chart. RSI is...